Lindbloom BJ, James ER, McGarvey WC: Osteomyelitis of the foot and ankle: diagnosis, epidemiology, and treatment. Foot Ankle Clin 19: 569, 2014.
Uckay I, Gariani K, Dubois-Ferriere V, et al: Diabetic foot infections: recent literature and cornerstones of management. Curr Opin Infect Dis 29: 145, 2016.
Wanivenhaus F, Mauler F, Stelzer T, et al: Revision rate and risk factors after lower extremity amputation in diabetic or dysvascular patients. Orthopedics 39: e149, 2016.
Waibel FWA, Klammer A, Gotschi T, et al: Outcome after surgical treatment of calcaneal osteomyelitis. Foot Ankle Int 40: 562, 2019.
Landry GJ, Silverman DA, Liem TK, et al: Predictors of healing and functional outcome following transmetatarsal amputations. Arch Surg 146: 1005, 2011.
Dunkel N, Belaieff W, Assal M, et al: Wound dehiscence and stump infection after lower limb amputation: risk factors and association with antibiotic use. J Orthop Sci 17: 588, 2012.
Kaiser P, Haller TV, Uckay I, et al: Revision after total transmetatarsal amputation. J Foot Ankle Surg 58: 1171, 2019.
Haller TV, Kaiser P, Kaiser D, et al: Outcome of ray resection as definitive treatment in forefoot infection or ischemia: a cohort study. J Foot Ankle Surg 59: 27, 2020.
Lebowitz D, Gariani K, Kressmann B, et al: Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection? Int J Infect Dis 59: 61, 2017.
Krajbich JI, Pinzur MS, Potter BK, et al: Atlas of Amputations and Limb Deficiencies, Lippincott Williams & Wilkins, Philadelphia, 2018.
Christensen KS, Falstie-Jensen N, Christensen ES, et al: Results of amputation for gangrene in diabetic and non-diabetic patients: selection of amputation level using photoelectric measurements of skin-perfusion pressure. J Bone Joint Surg Am 70: 1514, 1988.
Silbert S, Haimovici H: Criteria for the selection of the level of amputation for ischemic gangrene. J Am Med Assoc 155: 1554, 1954.
Dwars BJ, van den Broek TA, Rauwerda JA, et al: Criteria for reliable selection of the lowest level of amputation in peripheral vascular disease. J Vasc Surg 15: 536, 1992.
Romano RL, Burgess EM: Level selection in lower extremity amputations. Clin Orthop Relat Res 74: 177, 1971.
Sarin S, Shami S, Shields DA, et al: Selection of amputation level: a review. Eur J Vasc Surg 5: 611, 1991.
Biehl C, Eckhard M, Szalay G, et al: Minor foot amputations in diabetic foot syndrome [in German]. Oper Orthop Traumatol 28: 365, 2016.
Bowker JH, Michael JW; American Academy of Orthopaedic Surgeons: Atlas of Limb Prosthetics: Surgical, Prosthetic, and Rehabilitation Principles, 2nd Ed, Mosby–Year Book, St. Louis, 1992.
Atnip R: Toe and partial foot amputations. Oper Tech General Surg 7: 67, 2005.
Graham WP III, Pataky PE, Whitaker LA, et al: Transarticular joint amputations: the value of preserving articular cartilage. J Surg Res 14: 524, 1973.
Aragón-Sánchez J, Lipsky BA: Modern management of diabetic foot osteomyelitis: the when, how and why of conservative approaches. Expert Rev Anti Infect Ther 16: 35, 2018.
Pinzur MS: Current concepts: amputation surgery in peripheral vascular disease. Instr Course Lect 46: 501, 1997.
Donovan A, Schweitzer ME: Use of MR imaging in diagnosing diabetes-related pedal osteomyelitis. Radiographics 30: 723, 2010.
Lipsky BA, Peters EJ, Senneville E, et al: Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 28 (suppl 1): 163, 2012.
Gholamrezanezhad A, Basques K, Batouli A, et al: Clinical nononcologic applications of PET/CT and PET/MRI in musculoskeletal, orthopedic, and rheumatologic imaging. AJR Am J Roentgenol 210: W245, 2018.
Lipsky BA, Berendt AR, Cornia PB, et al: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54: e132, 2012.
Faglia E, Clerici G, Caminiti M, et al: Influence of osteomyelitis location in the foot of diabetic patients with transtibial amputation. Foot Ankle Int 34: 222, 2013.
Bowker JH: Partial foot and Syme amputations: an overview. Clin Prosthet Orthot 12: 10, 1987.
Winkler E, Schöni M, Krähenbühl N, et al: Foot osteomyelitis location and rates of primary or secondary major amputations in patients with diabetes. Foot Ankle Int 43: 957, 2022.
Baumgartner R, Wetz HH: Forefoot amputation. Orthop Traumatol 1: 68, 1992.
Hart PA, Bellin MD, Andersen DK, et al: Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1: 226, 2016.
Grayson ML, Gibbons GW, Balogh K, et al: Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 273: 721, 1995.
Glaudemans AW, Uckay I, Lipsky BA: Challenges in diagnosing infection in the diabetic foot. Diabet Med 32: 748, 2015.
Lipsky BA, Senneville É, Abbas ZG, et al: Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 36 (suppl 1): e3280, 2020.
Gariani K, Lebowitz D, von Dach E, et al: Remission in diabetic foot infections: duration of antibiotic therapy and other possible associated factors. Diabetes Obes Metab 21: 244, 2019.
Webster AC, Nagler EV, Morton RL, et al: Chronic kidney disease. Lancet 389: 1238, 2017.
Faglia E, Clerici G, Frykberg R, et al: Outcomes of Chopart amputation in a tertiary referral diabetic foot clinic: data from a consecutive series of 83 hospitalized patients. J Foot Ankle Surg 55: 230, 2016.
Garbalosa JC, Cavanagh PR, Wu G, et al: Foot function in diabetic patients after partial amputation. Foot Ankle Int 17: 43, 1996.
Hazari A, Maiya AG, Shivashankara KN: Foot kinetic and kinematic profile in type 2 diabetes mellitus with peripheral neuropathy: a hospital-based study from South India. JAPMA 109: 36, 2019.
Borg I, Mizzi S, Formosa C: Plantar pressure distribution in patients with diabetic peripheral neuropathy and a first-ray amputation. JAPMA 108: 225, 2018.
Acar E, Kacira BK: Predictors of lower extremity amputation and reamputation associated with the diabetic foot. J Foot Ankle Surg 56: 1218, 2017.
Ahn J, Raspovic KM, Liu GT, et al: Renal function as a predictor of early transmetatarsal amputation failure. Foot Ankle Spec 12: 439, 2019.
Elsherif M, Tawfick W, Canning P, et al: Quality of time spent without symptoms of disease or toxicity of treatment for transmetatarsal amputation versus digital amputation in diabetic patients with digital gangrene. Vascular 26: 142, 2018.
Lavery LA, Armstrong DG, Boulton AJ: Ankle equinus deformity and its relationship to high plantar pressure in a large population with diabetes mellitus. JAPMA 92: 479, 2002.
Searle A, Spink MJ, Chuter VH: Prevalence of ankle equinus and correlation with foot plantar pressures in people with diabetes. Clin Biomech (Bristol, Avon) 60: 39, 2018.
Searle A, Spink MJ, Ho A, et al: Association between ankle equinus and plantar pressures in people with diabetes: a systematic review and meta-analysis. Clin Biomech (Bristol, Avon) 43: 8, 2017.
Background: Reamputations are frequent after minor amputations performed for diabetic foot osteomyelitis (DFO). Whether the type of amputation is associated with a particular outcome is unknown. The aim of this study was to evaluate whether amputations of the transarticular compared with the transosseous type have different rates of clinical and microbiological failure.
Methods: We actively followed 284 patients with DFO (543 episodes of minor foot amputations: 203 transarticular and 340 transosseous) for 1 year. We assessed the long-term effect of transarticular compared with transosseous amputations on the rates of clinical and microbiological failure using comparative statistics, log-rank survival analyses, Kaplan-Meier curves, and multivariate Cox regressions.
Results: In 122 episodes (22.5%) there was clinical failure that led to reamputation. The difference in the risk of clinical failure of transarticular versus transosseous amputations was nonsignificant (44 [21.7%] versus 78 [22.9%]; Pearson χ2 test: P = .73). Similarly, the difference in microbiological failure (32 episodes, 5.9% overall) between groups was nonsignificant (11 [5.4%] and 21 [6.2%], respectively; P = .72). The mean time between the index surgery and clinical failure was 2.2 months for transarticular and 3.2 months for transosseous amputations (Mann-Whitney U test; P = .39). Survival analyses showed similar evolutions for each group (log-rank test; P = .85). In the multivariate Cox regression analysis, the type of amputation did not significantly influence clinical or microbiological failures.
Conclusions: In DFO, there is no significant difference between transarticular and transosseous amputations within 1 year in the incidence of clinical or microbiological failures.